WWC1, a target of miR-138-5p, facilitates the progression of prostate cancer

被引:2
作者
Liu, Miao [1 ]
Liu, Shiguo [1 ]
Chen, Feng [1 ,2 ]
机构
[1] Third Peoples Hosp Hubei Prov, Dept Lab, Wuhan 430033, Hubei, Peoples R China
[2] Third Peoples Hosp Hubei Prov, Dept Lab, 26 Zhongshan Ave, Wuhan 430033, Hubei, Peoples R China
关键词
WWC1; miR-138-5p; Prostate cancer; Proliferation; Apoptosis; KIBRA; TRANSITION; EXPRESSION; SURVIVAL; PATHWAY;
D O I
10.1016/j.amjms.2022.08.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: WWC1 is known to be involved in the development of cancer. Therefore, it is critical to study the molecular mechanisms and cellular roles of WWC1 in cancer therapy.Methods: In this study, we examined the effect of WWC1 on prostate cancer tumorigenesis and the role of miR-138-5p in prostate cancer. The expression levels of miR-138-5p and WWC1 in prostate cancer (Pca) tissues and cells were detected by real-time quantitative reverse transcription PCR and western blotting. Cell counting kit-8 and BrdU assays were performed to study cell proliferation and caspase-3 activity assay to detect apoptosis. Migration experiments were conducted to observe the movement ability of the cells.Results: The expression of WWC1 in Pca tissues or cell lines was increased, whereas miR-138-5p expression was decreased. MiR-138-5p targeted and partially neutralized the role of WWC1 in Pca cells. Moreover, reduced expression of WWC1 in Pca cell lines suppressed cell proliferation and migration and promoted apoptosis in vitro. Conclusions: Collectively, these findings reveal a novel mechanism by which miR-138-5p negatively regulates WWC1 in Pca.
引用
收藏
页码:772 / 781
页数:10
相关论文
共 22 条
[1]   LINC00992 contributes to the oncogenic phenotypes in prostate cancer via targeting miR-3935 and augmenting GOLM1 expression [J].
Chen, Jianheng ;
Liu, Xiaodong ;
Ke, Kunbin ;
Zou, Jianan ;
Gao, Zhan ;
Habuchi, Tomonori ;
Yang, Xuezhen .
BMC CANCER, 2020, 20 (01)
[2]   MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells [J].
Dong, Peixin ;
Xiong, Ying ;
Watari, Hidemichi ;
Hanley, Sharon J. B. ;
Konno, Yosuke ;
Ihira, Kei ;
Yamada, Takahiro ;
Kudo, Masataka ;
Yue, Junming ;
Sakuragi, Noriaki .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2016, 35
[3]   MiR-26a and miR-138 block the G1/S transition by targeting the cell cycle regulating network in prostate cancer cells [J].
Erdmann, Kati ;
Kaulke, Knut ;
Rieger, Christiane ;
Salomo, Karsten ;
Wirth, Manfred P. ;
Fuessel, Susanne .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (11) :2249-2261
[4]   The mir-200 family and mir-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 [J].
Gregory, Philip A. ;
Bert, Andrew G. ;
Paterson, Emily L. ;
Barry, Simon C. ;
Tsykin, Anna ;
Farshid, Gelareh ;
Vadas, Mathew A. ;
Khew-Goodall, Yeesim ;
Goodall, Gregory J. .
NATURE CELL BIOLOGY, 2008, 10 (05) :593-601
[5]   Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial [J].
Grubb, Robert L., III ;
Pinsky, Paul F. ;
Greenlee, Robert T. ;
Izmirlian, Grant ;
Miller, Anthony B. ;
Hickey, Thomas P. ;
Riley, Thomas L. ;
Mabie, Jerome E. ;
Levin, David L. ;
Chia, David ;
Kramer, Barnett S. ;
Reding, Douglas J. ;
Church, Timothy R. ;
Yokochi, Lance A. ;
Kvale, Paul A. ;
Weissfeld, Joel L. ;
Urban, Donald A. ;
Buys, Saundra S. ;
Gelmann, Edward P. ;
Ragard, Lawrence R. ;
Crawford, E. David ;
Prorok, Philip C. ;
Gohagan, John K. ;
Berg, Christine D. ;
Andriole, Gerald L. .
BJU INTERNATIONAL, 2008, 102 (11) :1524-1530
[6]   EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent-Update 2013 [J].
Heidenreich, Axel ;
Bastian, Patrick J. ;
Bellmunt, Joaquim ;
Bolla, Michel ;
Joniau, Steven ;
van der Kwast, Theodor ;
Mason, Malcolm ;
Matveev, Vsevolod ;
Wiegel, Thomas ;
Zattoni, F. ;
Mottet, Nicolas .
EUROPEAN UROLOGY, 2014, 65 (01) :124-137
[7]   MicroRNA hsa-miR-4674 in Hemolysis-Free Blood Plasma Is Associated with Distant Metastases of Prostatic Cancer [J].
Knyazev, E. N. ;
Samatov, T. R. ;
Fomicheva, K. A. ;
Nyushko, K. M. ;
Alekseev, B. Ya. ;
Shkurnikov, M. Yu. .
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2016, 161 (01) :112-115
[8]   Characterization of KIBRA, a novel WW domain-containing protein [J].
Kremerskothen, J ;
Plaas, C ;
Büther, K ;
Finger, I ;
Veltel, S ;
Matanis, T ;
Liedtke, T ;
Barnekow, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 300 (04) :862-867
[9]   Diagnostic Assay Based on hsa-miR-205 Expression Distinguishes Squamous From Nonsquamous Non-Small-Cell Lung Carcinoma [J].
Lebanony, Danit ;
Benjamin, Hila ;
Gilad, Shlomit ;
Ezagouri, Meital ;
Dov, Avital ;
Ashkenazi, Karin ;
Gefen, Nir ;
Izraeli, Shai ;
Rechavi, Gideon ;
Pass, Harvey ;
Nonaka, Daisuke ;
Li, Junjie ;
Spector, Yael ;
Rosenfeld, Nitzan ;
Chajut, Ayelet ;
Cohen, Dalia ;
Aharonov, Ranit ;
Mansukhani, Mahesh .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (12) :2030-2037
[10]   WWC1 promotes podocyte survival via stabilizing slit diaphragm protein dendrin [J].
Lin, Ting ;
Zhang, Li ;
Liu, Shuangxin ;
Chen, Yuanhan ;
Zhang, Hong ;
Zhao, Xingchen ;
Li, Ruizhao ;
Zhang, Qianmei ;
Liao, Ruyi ;
Huang, Zongshun ;
Zhang, Bin ;
Wang, Wenjian ;
Liang, Xinling ;
Shi, Wei .
MOLECULAR MEDICINE REPORTS, 2017, 16 (06) :8685-8690